Sampablo I, Escarrabill J, Rosell A, Manresa F, Estopá R
Pneumology Service, Hospital Princeps d'Espanya, L'Hospitalet, Barcelona, Spain.
Monaldi Arch Chest Dis. 1998 Apr;53(2):123-6.
The acceptance of transtracheal catheters (TTC) in chronic obstructive pulmonary disease (COPD) patients with severe hypoxaemia was analysed and the adverse events associated with this system of oxygenation described. Once the TTC (Oxycat) was inserted, each patient was monitored on an outpatient basis and information about the associated adverse events was collected. In a group of 70 patients that met the inclusion criteria, only 14 (20%) accepted TTC insertion. The observed adverse events were: haemorrhage through the stoma (3); ejection of the TTC in a cough reflex (2); subcutaneous emphysema (2); mucous plugging (1); and haemoptysis (1). Removal of the TTC was necessary in 29% of the cases, and was associated with the onset of an adverse event in all cases except one. Despite the proven benefits of oxygen therapy performance and the improvement in effort tolerance, transtracheal catheter has a low level of acceptance among patients with extremely disabling diseases. The adverse events observed were frequent, but could have been corrected and in no case worsened our patients' prognosis.
分析了慢性阻塞性肺疾病（COPD）严重低氧血症患者对经气管导管（TTC）的接受情况，并描述了与该氧合系统相关的不良事件。一旦插入TTC（Oxycat），对每位患者进行门诊监测，并收集有关相关不良事件的信息。在一组符合纳入标准的70例患者中，只有14例（20%）接受了TTC插入。观察到的不良事件有：造口出血（3例）；咳嗽反射时TTC弹出（2例）；皮下气肿（2例）；黏液堵塞（1例）；咯血（1例）。29%的病例需要取出TTC，除1例外，所有病例均与不良事件的发生有关。尽管氧疗已被证明有益且运动耐力有所改善，但经气管导管在患有极度致残性疾病的患者中接受度较低。观察到的不良事件很常见，但本可得到纠正，且在任何情况下均未恶化我们患者的预后。
